Suzhou, China

Wenming Chen


Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Wenming Chen and His Contribution to Cancer Treatment

Introduction: Wenming Chen is a distinguished inventor based in Suzhou, China. He is recognized for his groundbreaking work in the field of pharmaceuticals, particularly relating to the development of compounds that inhibit Mcl-1, a protein that plays a crucial role in cancer cell survival. With a significant patent under his name, Chen continues to make strides in cancer treatment through innovative research.

Latest Patents: One of Wenming Chen’s most notable patents is titled "Macrocyclic indoles as Mcl-1 inhibitors." This patent, which consists of a compound of formula I and its pharmaceutically acceptable salts and solvates, addresses the treatment of conditions or disorders responsive to Mcl-1 inhibition, with a particular focus on cancer. The detailed specification outlines the specific structures involved, enabling advancements in therapeutic applications for oncological conditions.

Career Highlights: Wenming Chen has had a notable career, having held positions at Ascentage Pharma (Suzhou) Co., Ltd. and the University of Michigan. His experiences in these respected institutions have contributed to his expertise in medicinal chemistry and drug development, enabling him to innovate and push the boundaries of current cancer therapies.

Collaborations: Throughout his career, Chen has collaborated with several talented individuals, including Hao Chen and Chao Li. These collaborations have fostered a productive environment for developing new approaches to combatting cancer through innovative pharmaceuticals.

Conclusion: Wenming Chen's contributions to the field of cancer treatment through his patented work exemplify the vital role of inventors in advancing medical science. His dedication to developing effective therapies highlights the importance of innovation in addressing pressing global health challenges. As he continues his research, the potential impact of his work may lead to significant improvements in cancer treatment and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…